MOLECULAR CHARACTERIZATION OF CARBAPENEMASE GENES (CARBA 5) AMONG MULTIDRUG-RESISTANT OCULAR PATHOGENS IN CENTRAL INDIA
Main Article Content
Keywords
Ocular infections, Multidrug-resistant bacteria, Carbapenem resistance, Carbapenemase genes, Carba 5 rapid test.
Abstract
Background: Ocular infections caused by multidrug-resistant (MDR) bacteria, especially those harboring carbapenemase enzymes, pose a significant challenge to effective treatment and can lead to severe visual impairment. Carbapenemase genes such as bla KPC, bla NDM, bla VIM, bla IMP, and bla OXA-48-like contribute to carbapenem resistance and are detectable by the Carba 5 molecular panel.
Aim: To molecular characterize carbapenemase genes among MDR ocular bacterial pathogens from a tertiary care hospital in Central India and evaluate their antibiotic resistance patterns.
Methods: A Observational study were conducted from January 2024 to January 2025 involving 250 ocular specimens. Bacterial isolates were identified and tested for antibiotic susceptibility according to CLSI guidelines (2021). MDR carbapenem-resistant isolates underwent phenotypic screening followed by genotypic detection of carbapenemase genes using the NG-Test CARBA 5 rapid immune chromatographic assay, with confirmation.
Results: A total of 250 ocular specimens were analyzed, with 84% yielding bacterial growth. Conjunctival swabs were the most common source, followed by corneal scrapings and lacrimal sac discharge. Among the 210 isolates, Staphylococcus aureus was the predominant pathogen, with Gram-negative bacilli such as Pseudomonas aeruginosa and Klebsiella pneumoniae also significantly represented. Multidrug resistance was observed in isolates, 9 (4.2%) that showed. Among 80 Gram-negative isolates tested, 4 were meropenem-resistant; 3 of these were confirmed carbapenemase producers (NDM, KPC, OXA-48) using mCIM and Carba 5 tests. One isolate showed non-carbapenemase resistance. These findings highlight the rising burden of MDR and carbapenemase-producing pathogens in ocular infections.
Conclusion: The high prevalence of carbapenemase-producing MDR ocular pathogens, predominantly carrying bla NDM, highlights the urgent need for routine molecular screening and antibiotic stewardship in ophthalmic care. Rapid detection using the Carba 5 test facilitates timely and targeted therapy, essential for preserving vision and controlling antimicrobial resistance in ocular infections.
References
2) Das S, Sharma S, Kar S, et al. Bacterial keratitis: epidemiology, clinical features, and outcome. Indian J Ophthalmology. 2009;57(2):85–90.
3) Sharma S, Das S, Kar S. Antibiotic resistance in ocular pathogens: emerging trends. Indian Journal Medical Research. 2016;143(5):580–87.
4) Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–98.
5) Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiology Rev. 2007;20(3):440–58.
6) Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707.
7) Gajiwala A, Sahay P, Kamat S, et al. Emerging antibiotic resistance among ocular pathogens: a tertiary care study. Int Journal Ophthalmology. 2018;11(9):1461–66.
8) Doyle D, Peirano G, Lascols C, et al. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiology. 2012;50(12):3877–80.
9) Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott’s Diagnostic Microbiology. 13th ed. St. Louis: Mosby Elsevier; 2014.
10) Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne, PA: CLSI; 2021.
11) Dortet L, Poirel L, Errera C, Nordmann P. CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J Clin Microbiology 2014;52(7):2359–64.
12) Boutal H, Vogel A, Bernabeu S, et al. Development and validation of a lateral flow immunoassay for rapid detection of NDM-producing Enterobacteriaceae. J Clin Microbiol. 2018;56(8):e01368-78.
13) Sharma S, Jindal A, Das S, Joseph J. Emerging trends in antibiotic resistance of ocular pathogens in India: A 10-year analysis. Indian J Ophthalmology 2020;68(2):184–90.
14) Silpa-Archa S, Singhakul J, Kunavisarut P, et al. Trends in antibiotic resistance of ocular bacterial pathogens at a tertiary eye care center in Thailand. Br J Ophthalmology. 2021;105(8):1093–98.
15) Ahmed SA, Kumar A, Singh N. The role of carbapenem-resistant Enterobacteriaceae in ocular infections. Antimicrob Resist Infect Control. 2019;8(1):70.
16) Datta S, Wattal C, Goel N, et al. A ten-year analysis of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa from a tertiary care hospital in India. Indian J Med Research 2012;135(6):814–18.
17) Cointe A, Bogaerts P, Decré D, et al. Evaluation of the NG-Test Carba 5 for rapid detection of carbapenemases in Enterobacterales. J Antimicrob Chemother. 2020;75(3):562–66.
18) Teweldemedhin M, Saravanan M, Gebreyesus H, Selvaraj C. Bacterial profile of ocular infections: A systematic review. BMC Ophthalmol. 2017;17(1):212.